Exor N.V (EXO) Fair Value & Analysis
Industrials · NL · Market cap €22.6B
Fair value as of: Aug 9, 2026
From 2 valuation models · updated today
Fair value updated Aug 9, 2026, revised from €13.05 to €129.45 (+892.0%) since Jul 19, 2026. Share price +4.1% over the past month.
A solid business, screening 83% undervalued on our models.
What matters now
- The price is below even our cautious bear case (€97.09). The market is more pessimistic than our downside scenario.
- Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 9, 2026.
How to read this chart
48‑month range €58.63 – €103.57 · fair‑value band €97.09 – €161.81 · the €70.55 price screens below the €129.45 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 9, 2026.
Analysis
Exor N.V (EXO) currently trades at €70.55, while our model-based Fair Value estimate is €129.45, implying the stock looks roughly 83.5% undervalued today. The Quality Score stands at 60/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
It earns a return on equity of -10.6%. The balance sheet holds a net cash position of €1.4B. Fundamentals as of Aug 9, 2026
Our scenario range runs from €97.09 (bear case) to €161.81 (bull case); at €70.55, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 23% below its 52-week high and 19% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -14% fair-value upside, at 83%, EXO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Multiples (€139.72) versus Asset-Based (€110.13). Highest evidence: P/B Multiple (55).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 9, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 49
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Exor N.V. engages in the automotive, agriculture and construction, sports car, commercial vehicle, health technology, football and powertrain businesses in the Netherlands and internationally. The company designs, engineers, produces, and sells luxury performance sports cars under the Ferrari brand.
Full company description
Exor N.V. engages in the automotive, agriculture and construction, sports car, commercial vehicle, health technology, football and powertrain businesses in the Netherlands and internationally. The company designs, engineers, produces, and sells luxury performance sports cars under the Ferrari brand. It also provides automotive vehicles and mobility solutions under the Abarth, Alfa Romeo, Chrysler, Citroen, Dodge, DS, Fiat, Fiat Professional, Jeep, Lancia, Maserati, Mopar, Opel, Peugeot, Ram, and Vauxhall brands; diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatic, and personal health equipment under Philips brand; agricultural and construction equipment and services; heavy, medium, and light-duty trucks; powertrain technologies; mass-transit and premium buses and coaches; defense and civil protection equipment; heavy-duty quarry and construction vehicles; and firefighting vehicles and equipment, as well as financing services. In addition, the company offers men's footwear, leather goods, beauty, and accessories; equipment for the building and repairing of oil and gas wells; clean energy solutions; data, insights and analytics, expert, and workflow solutions; information through newspapers and magazines to conferences and electronic services and publishes The Economist; and apparel, furniture, homeware, and jewelry products. Further, it engages in the management of professional football teams under the Juventus Football Club name; and hospitals and outpatient clinics, as well as operates as investment management company and technology company specializing in the data-driven optimization of public mobility systems. Exor N.V. was founded in 1899 and is headquartered in Amsterdam, the Netherlands. Exor N.V. is a subsidiary of Giovanni Agnelli B.V.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Exor N.V reported revenue of €1.0B in FY2025 versus €33.6B in FY2021, a compound −58.0%/yr. Reported net income was −€3.8B in FY2025.
Watch EXO: get an alert when its fair value changes →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Exor Press Release - Leadership Changes
- A Look At Exor (ENXTAM:EXO) Valuation After Dividend Approval And Board Changes
- Exor Press Release - 2026 AGM
- Exor Press Release - Png and Della Chiesa Nominations
Peer Group
Farm & Heavy Construction Machinery · 148 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Farm & Heavy Construction Machinery median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Farm & Heavy Construction Machinery stocks, each showing price versus our Fair Value estimate (as of Aug 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Caterpillar Inc CAT | $952.41 | $307.83 | -68% |
| Deere & Company DE | $597.24 | $187.86 | -69% |
| AB Volvo (publ), VOLVA | kr 336.60 | kr 288.08 | -14% |
| PACCAR Inc PCAR | $126.20 | $94.80 | -25% |
| Epiroc AB EPIA | kr 251.90 | kr 144.14 | -43% |
| Sany Heavy Industry Co 600031 | ¥18.65 | ¥20.84 | +12% |
| XCMG Construction Machinery Co 000425 | ¥8.39 | ¥11.79 | +41% |
| Sinotruk (Hong Kong) Limited 3808 | HK$41.00 | HK$53.51 | +31% |
| Yutong Bus Co 600066 | ¥32.29 | ¥42.00 | +30% |
| Ashok Leyland Limited ASHOKLEY | ₹157.49 | ₹124.10 | -21% |
Compare Exor N.V with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Exor N.V (EXO) overvalued or undervalued?
What is the fair value of EXO?
What is the quality score of EXO?
What is the net profit margin of EXO?
Does Exor N.V pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Exor N.V and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.